discovered a novel BCL11B-ZEB2 fusion in rare cases of ETP-ALL, which is thought to drive increased ZEB2 expression through the 5’ BCL11B fusion partner (156). This evidence concerns the gene ZEB2 and acute lymphoblastic leukemia.